Publications

(2021). Revisiting a null hypothesis: exploring the parameters of oligometastasis treatment. International Journal of Radiation Oncology Biology* Physics*.

Cite

(2021). Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC. Journal of Thoracic Oncology.

Cite

(2020). UV sterilization of personal protective equipment with idle laboratory biosafety cabinets during the Covid-19 pandemic. MedRxiv.

Cite

(2020). Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma. Iscience.

Cite

(2020). GARD is a pan-cancer predictor of clinical outcome in radiation treated patients.. medRxiv.

Cite

(2020). Exploiting convergent evolution to derive a cisplatin sensitivity gene expression signature in epithelial based cancer. American Association for Cancer Research.

Cite

(2020). A Multi-Outcome Meta-Analysis Method Reveals the Genomic Adjusted Radiation Dose is a Continuous Predictive Biomarker of Radiation Outcome. International Journal of Radiation Oncology, Biology, Physics.

Cite

(2019). Network potential identifies therapeutic miRNA cocktails in Ewings Sarcoma. bioRxiv.

Cite

(2019). Identifying states of collateral sensitivity during the evolution of therapy resistance in Ewing’s sarcoma. AACR.

Cite

(2017). Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV). Infection, Genetics and Evolution.

Cite